Get started
Markets US Stocks Health Technology Biotechnology

Frequency Therapeutics, Inc

FREQ NASDAQ
FREQ
Frequency Therapeutics, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
Ideas Financials Technicals

FREQ Stock Chart

Ideas

Videos only
Triangle
FREQ
, 1D Short
FREQ: Triangle

Down trend continuation?

Frequency Therapeutics Inc🧙
FREQ
, 1D
Long
FREQ: Frequency Therapeutics Inc🧙

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being...

Does FREQ fill the gap?
FREQ
, 1D
Long
FREQ: Does FREQ fill the gap?

Freq fall hard, when they product treating hearing loss did not show any improvement. Does it need good news to recover and fill the gap? Last days Freq is detached from nasdaq. In one month chart forming bullish cup and handle. It is not financial advice. Do you own search.

SELL PUT OPTIONS AT STRIKE 15.00USD (FREQ)
FREQ
, 1D
FREQ: SELL PUT OPTIONS AT STRIKE 15.00USD (FREQ)

Budget 10,000USD Stocks covered: 666 No leverage. Received premium: 666USD Profit per day: 24,66 USD Pace at 90,03% p.a. Risk: this is up to you, you can close the position when you reach your max. desired loss. Its good to use discretionary approach and manage the risk from day to day. If the price will not fall rapidly than time is our friend and the profit...

FREQ 4days:: Best level to BUY // 200%+ SWING trade (STOCKS)
FREQ
, 4D Short
FREQ: FREQ 4days:: Best level to BUY // 200%+ SWING trade (STOCKS)

Why get subbed to to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates FREQ 4days:: Best level to BUY // 200%+ SWING trade...

$FREQ #FREQ very interested to find out where is landing here
FREQ
, 60
Long
FREQ: $FREQ #FREQ very interested to find out where is landing here

last candle is very rude , but will be interesting to find the way it turn around or goes ball

Hearing damage cure?
FREQ
, 1D
Long
FREQ: Hearing damage cure?

The gamble of a lifetime?

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Biotechnology
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The firm's progenitor cell activation approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Breaking news